The project consists in a Pilot Implementation Project of Methadone and Buprenorphine/ Naloxone (Suboxone®) for Injecting Drug Users in Ho Chi Minh City, Vietnam. It evaluates the implementation of a Medication Assisted Treatment (MAT) program that includes pharmacological treatment with both methadone and buprenorphine/naloxone, counseling sessions on drugs and HIV, integrated within an HIV treatment setting. This is the first project to establish a treatment program that is dedicated to treat opioids addiction and HIV within the same clinic; and also the first time that buprenorphine/naloxone (Suboxone®) treatment is used in Vietnam. Up to 500 injection opioids users will be enrolled in the program.
The project is collaboration between:
- The Center for Studies of Addiction of University of Pennsylvania, Philadelphia, USA
- The Provincial AIDS Committee (PAC) of Ho Chi Minh City, Vietnam
- ESTHER (“Ensemble pour une Solidarité Thérapeutique Hospitalière En Réseau” – Network for Therapeutic Solidarity in Hospitals), a French led initiative to expand access to HIV prevention and treatment services
- The USR CNRS 3413 SANPsy of the University of Bordeaux and Bizia Addiction Clinic, France
The specific aims of the project are:
- To establish a new integrated MAT treatment program within and HIV treatment setting in Ho Chi Minh City;
- To evaluate the barriers and the facilitators to implement an integrated MAT/HIV treatment;
- To evaluate the retention and the medication adherence in integrated MAT/HIV Care;
- To estimate the costs and benefits of MAT treatment strategies.
The project is funded by the NIDA grant R01- DA033671-01.